Michael Gelband ExodusPoint Capital Management
Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$272M |
| 2 |
Meta Platforms (Facebook)
META
|
+$79.7M |
| 3 |
NVIDIA
NVDA
|
+$74.6M |
| 4 |
Procter & Gamble
PG
|
+$60.5M |
| 5 |
Microsoft
MSFT
|
+$58.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PARA
Paramount Global Class B
PARA
|
+$158M |
| 2 |
PPL
PPL Corp
PPL
|
+$113M |
| 3 |
Southern Company
SO
|
+$111M |
| 4 |
Danaher
DHR
|
+$106M |
| 5 |
Entergy
ETR
|
+$84.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.92% |
| 2 | Industrials | 9.39% |
| 3 | Financials | 9.29% |
| 4 | Consumer Discretionary | 7.56% |
| 5 | Utilities | 6.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1126
Intercontinental Exchange
ICE
$91.5B
| $615K | 0.01% |
3,648
-8,293
| -69% | -$1.48M |
|
1127
Xperi
XPER
$302M
| $614K | 0.01% |
+94,709
| New | +$625K |
|
|
INN
1128
Summit Hotel Properties
INN
$662M
| $611K | 0.01% |
111,373
-52,647
| -32% | -$287K |
|
1129
RxSight
RXST
$260M
| $606K | 0.01% |
+67,422
| New | +$592K |
|
1130
Community Trust Bancorp
CTBI
$1.39B
| $606K | 0.01% |
10,829
-2,211
| -17% | -$124K |
|
1131
Ryman Hospitality Properties
RHP
$9.05B
| $599K | 0.01% |
+6,688
| New | +$654K |
|
1132
Camtek
CAMT
$6.64B
| $596K | 0.01% |
+5,672
| New | +$508K |
|
1133
Pediatrix Medical
MD
$2.16B
| $591K | 0.01% |
35,294
+11,411
| +48% | +$171K |
|
1134
Bumble
BMBL
$376M
| $587K | 0.01% |
96,406
-37,742
| -28% | -$258K |
|
1135
Enova International
ENVA
$6.17B
| $585K | 0.01% |
5,083
-48,758
| -91% | -$5.57M |
|
1136
MiMedx Group
MDXG
$622M
| $579K | 0.01% |
82,968
+71,233
| +607% | +$495K |
|
1137
Matrix Service
MTRX
$301M
| $576K | 0.01% |
+44,050
| New | +$626K |
|
1138
CALL
Applied Digital
APLD
$7.64B
| $574K | 0.01% |
+25,000
| New | +$370K |
|
1139
PUT
TeraWulf
WULF
$7.72B
| $571K | 0.01% |
+50,000
| New | +$382K |
|
1140
B2Gold
BTG
$7.56B
| $568K | 0.01% |
+114,838
| New | +$452K |
|
1141
Calumet Specialty Products
CLMT
$4.16B
| $566K | 0.01% |
+31,023
| New | +$510K |
|
1142
Neurogene
NGNE
$793M
| $564K | 0.01% |
+32,521
| New | +$653K |
|
1143
AerSale
ASLE
$268M
| $562K | 0.01% |
68,592
+30,780
| +81% | +$232K |
|
1144
CALL
Compass
COMP
$8.87B
| $562K | 0.01% |
+70,000
| New | +$567K |
|
1145
The Greenbrier Companies
GBX
$1.43B
| $562K | 0.01% |
+12,167
| New | +$580K |
|
1146
Veeco
VECO
$2.86B
| $557K | 0.01% |
+18,312
| New | +$436K |
|
1147
KRONOS Worldwide
KRO
$1B
| $556K | 0.01% |
+96,801
| New | +$586K |
|
1148
Unilever
UL
$141B
| $554K | 0.01% |
+8,304
| New | +$573K |
|
1149
State Street Real Estate Select Sector SPDR ETF
XLRE
$8.54B
| $553K | 0.01% |
+13,134
| New | +$549K |
|
1150
Collegium Pharmaceutical
COLL
$848M
| $553K | 0.01% |
+15,802
| New | +$549K |
|
Similar funds
Michael Gelband's Q3 2025 Portfolio in Review
As of Q3 2025, Michael Gelband held 2,139 positions worth $9.79B, down 14% from $11.4B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Michael Gelband withdrew a net $2.29B in Q3 2025, closing 673 positions and reducing 386 holdings. Its most notable exit was Paramount Global Class B, an estimated $158M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 7.6% a quarter earlier, followed by Industrials and Financials.
Against the trend, Michael Gelband opened a new position in Apple worth $306M.
- Michael Gelband's largest Q3 2025 buy was Apple: 1,202,327 shares worth $306M.
- Michael Gelband added most to Procter & Gamble in Q3 2025, an estimated $60.5M increase.
- Michael Gelband's biggest Q3 2025 reduction was PPL Corp, cutting an estimated $113M.
- Michael Gelband fully exited Paramount Global Class B in Q3 2025, selling an estimated $158M.
- Michael Gelband's ten largest holdings make up 25% of its $9.79B portfolio in Q3 2025.
- Michael Gelband opened 733 new positions and closed 673 in Q3 2025.
- Michael Gelband's portfolio value fell 14% quarter-over-quarter to $9.79B.
Based on ExodusPoint Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.